EUVIMEDEUVIMED entdecken
Crossref

Dual‐Functional 10 B‐Doped Carbon Dots Enabling Glucose‐Based Cancer Cell Recognition and Boron Neutron Capture Therapy

Huanhuan Guo, Tianyuan Zhong, Miao Pang, Xinyi Fang, Yong Pan iD, Yubin Huang iD

Macromolecular Bioscience · 2026-04 · 26 (4)

DOI: 10.1002/mabi.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 20.04.2026. Verfasst von Huanhuan Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Northeast Normal University, Changchun, P.R. China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Glucose, Melanoma, Experimental. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Program, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boron neutron capture therapy (BNCT) is a tumor‐selective radiotherapy whose efficacy critically depends on efficient and preferential delivery of 10 B to cancer cells. Meanwhile, accurate early cancer diagnosis remains challenging due to subtle intracellular differences between malignant and normal cells. Herein, we report a multifunctional theranostic platform based on boron‐doped carbon dots (BCDs) that integrates cancer cell recognition with BNCT. Owing to the presence of boronic functionalities, the BCDs display enzyme‐free, selective, and interference‐resistant fluorescence enhancement in response to glucose, allowing reliable discrimination of cancer cells with elevated glucose uptake from normal cells. Upon neutron irradiation, BCDs exhibit potent cytotoxicity against B16‐F10 melanoma cells in vitro and achieve significant tumor growth suppression in murine melanoma models without systemic toxicity. Furthermore, the intrinsic fluorescence of BCDs enables real‐time tracking of 10 B biodistribution through cellular and ex vivo tissue imaging. This work establishes a novel theranostic paradigm by innovatively integrating fluorescence‐based cancer recognition into BNCT research, offering new design principles for next‐generation multifunctional BNCT agents and advancing integrated cancer diagnostics and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyGlucoseMelanoma, ExperimentalAnimalsCarbon Quantum DotsMiceCell Line, TumorHumansBoronCarbonIsotopes

Stichwörter der Autor:innen

bnctcarbon dotscell recognitionglucose‐sensing

Substanzen

GlucoseBoronBoron-10CarbonIsotopes

Autor:innen und Institutionen

  • Faculty of Chemistry, Northeast Normal University, Changchun, P.R. China.
  • Shenzhen Research Institute of Northeast Normal University, Northeast Normal University, Shenzhen, P.R. China.

ORCID-Profile: Yong Pan, Yubin Huang

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Science and Technology Program
  • Fundamental Research Funds for the Central Universities
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Guo, H., Zhong, T., Pang, M., Fang, X., Pan, Y., & Huang, Y. (2026). Dual‐Functional 10 B‐Doped Carbon Dots Enabling Glucose‐Based Cancer Cell Recognition and Boron Neutron Capture Therapy. Macromolecular Bioscience, 26(4). https://doi.org/10.1002/mabi.70185

Vancouver

Guo H, Zhong T, Pang M, Fang X, Pan Y, Huang Y. Dual‐Functional 10 B‐Doped Carbon Dots Enabling Glucose‐Based Cancer Cell Recognition and Boron Neutron Capture Therapy. Macromolecular Bioscience. 2026;26(4). doi:10.1002/mabi.70185

BibTeX
@article{Guo2026,
  author = {Guo, Huanhuan and Zhong, Tianyuan and Pang, Miao and Fang, Xinyi and Pan, Yong and Huang, Yubin},
  title = {Dual‐Functional 10 B‐Doped Carbon Dots Enabling Glucose‐Based Cancer Cell Recognition and Boron Neutron Capture Therapy},
  journal = {Macromolecular Bioscience},
  year = {2026},
  volume = {26},
  number = {4},
  doi = {10.1002/mabi.70185}
}
Kostenlos starten →